These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Discontinuation of thioridazine. What happened to thioridazine? Arshad P; Morcos M; Sridharan B BMJ; 2002 Oct; 325(7370):967. PubMed ID: 12402926 [No Abstract] [Full Text] [Related]
23. Exanthema medicamentosum as a side effect of promazine. Lasić D; Cvitanović MZ; Uglešić B; Višić V; Hlevnjak I Psychiatr Danub; 2011 Jun; 23(2):194-7. PubMed ID: 21685860 [TBL] [Abstract][Full Text] [Related]
24. [Antipsychotic agents, the keys to the opening of treatment practices]. Teixeira JL Soins Psychiatr; 2003; (228):27-9. PubMed ID: 14562555 [No Abstract] [Full Text] [Related]
25. The in vitro activity of phenothiazines against Mycobacterium avium: potential of thioridazine for therapy of the co-infected AIDS patient. Viveiros M; Martins M; Couto I; Kristiansen JE; Molnar J; Amaral L In Vivo; 2005; 19(4):733-6. PubMed ID: 15999542 [TBL] [Abstract][Full Text] [Related]
26. [Sonapax use in the clinical practice]. Siriachenko TM; Mikhaĭlova NM Voen Med Zh; 2005 Apr; 326(4):26-34. PubMed ID: 15962598 [No Abstract] [Full Text] [Related]
30. Piperacetazine versus thioridazine in the treatment of organic brain disease: a controlled double-blind study. Goldstein SE; Birnbom F J Am Geriatr Soc; 1976 Aug; 24(8):355-8. PubMed ID: 7588 [TBL] [Abstract][Full Text] [Related]
31. Hypotensive effect of phenothiazines. Turnbull JM Can Med Assoc J; 1966 Apr; 94(17):918. PubMed ID: 4157308 [No Abstract] [Full Text] [Related]
32. De novo treatment-resistant psychosis following thioridazine withdrawal. Bastiampillai T; Fantasia R; Nelson A Aust N Z J Psychiatry; 2014 Jun; 48(6):585-6. PubMed ID: 23908310 [No Abstract] [Full Text] [Related]
33. The prolongation of QTc-interval by thioridazine. Sachdev P Aust N Z J Psychiatry; 2001 Dec; 35(6):857-8. PubMed ID: 11990903 [No Abstract] [Full Text] [Related]
34. [Repercussions of the withdrawal of thioridazine]. Buj Alvarez I; Pifarré Paredero J; Idini E; Puigdevall Ruestes M Actas Esp Psiquiatr; 2008; 36(3):183-6. PubMed ID: 18478459 [TBL] [Abstract][Full Text] [Related]
35. Antipsychotics and sudden death: is thioridazine the only bad actor? Ray WA; Meador KG Br J Psychiatry; 2002 Jun; 180():483-4. PubMed ID: 12042224 [No Abstract] [Full Text] [Related]
36. Comparison of the effects of thioridazine and mesoridazine on the QT interval in healthy adults after single oral doses. Salih IS; Thanacoody RH; McKay GA; Thomas SH Clin Pharmacol Ther; 2007 Nov; 82(5):548-54. PubMed ID: 17410120 [TBL] [Abstract][Full Text] [Related]
37. [Combined treatment with hydergine and neuroleptics in mental disorders of old age]. Bukowczyk A; Wasik A; Horodnicki J Psychiatr Pol; 1969; 3(3):327-32. PubMed ID: 4980081 [No Abstract] [Full Text] [Related]
38. Thioridazine retinopathy. Hadden PW; Tay-Kearney ML; Barry CJ; Constable IJ Clin Exp Ophthalmol; 2003 Dec; 31(6):533-4. PubMed ID: 14641163 [No Abstract] [Full Text] [Related]
39. [Influence of MIKSTRA guidelines on clinical practice]. Rautakorpi UM; Koskinen H Duodecim; 2004; 120(24):2963-9. PubMed ID: 15700597 [No Abstract] [Full Text] [Related]
40. Discontinuation of thioridazine in patients with learning disabilities: balancing cardiovascular toxicity with adverse consequences of changing drugs. Davies SJ; Cooke LB; Moore AG; Potokar J BMJ; 2002 Jun; 324(7352):1519-21. PubMed ID: 12077046 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]